Table 5.
Univariable subdistribution regression for recurrence under the competing risk of death
| Variable | SHR1 (95% CI) | Wald test p value2 |
|---|---|---|
| Age, per 10-yr increase from baseline 60 years | 0.84 (0.63, 1.12) | 0.23 |
| Female | 1.45 (0.77, 2.71) | 0.249 |
| Rectum (v. colon) | 1.17 (0.52, 2.62) | 0.138 |
| Sigmoid/rectosigmoid (v. colon) | 2.01(0.94, 5.56) | – |
| Mucinous (v. adenocarcinoma) | 2.03 (0.81, 5.12) | 0.132 |
| Moderate grade (v. low grade) | 1.31 (0.636, 2.7) | 0.757 |
| High grade (v. low grade) | 1.12 (0.81, 5.12) | – |
| T3 stage v. T1/T2 stage | 2.46 (1.04, 5.81) | < 0.001 |
| T4 stage v. T1/T2 stage | 11.93 (3.74, 37.99) | – |
| N1 stage v. N0 stage | 2.02 (0.85, 4.8) | < 0.001 |
| N2 stage v. N0 stage | 10.58 (5.17, 21.65) | – |
| Vascular invasion | 4.27 (2.22, 8.21) | < 0.001 |
| Perineural invasion | 1.82 (0.95, 3.49) | 0.069 |
| Positive margins | 3.63 (1.68, 7.84) | 0.001 |
| Nodes examined (> 12) | 1.07 (0.53, 2.17) | 0.854 |
| Post-operative chemotherapy or radiation | 3.85 (1.99, 7.46) | < 0.001 |
1Subdistribution hazard ratio
2For the overall covariate